Cargando…

Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree

OBJECTIVES: Currently, in China, several strategies exist to prevent mother-to-child transmission (MTCT) of the hepatitis B virus (HBV). These include providing Hepatitis B vaccination and hepatitis B immunoglobulin (HBIG) injection with different types of administration and dosages. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Nan, Lei, Lei, Meng, Yiyu, Zhou, Naitong, Shi, Lizheng, Hu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256498/
https://www.ncbi.nlm.nih.gov/pubmed/35801242
http://dx.doi.org/10.3389/fpubh.2022.662442
_version_ 1784741129213706240
author Yang, Nan
Lei, Lei
Meng, Yiyu
Zhou, Naitong
Shi, Lizheng
Hu, Ming
author_facet Yang, Nan
Lei, Lei
Meng, Yiyu
Zhou, Naitong
Shi, Lizheng
Hu, Ming
author_sort Yang, Nan
collection PubMed
description OBJECTIVES: Currently, in China, several strategies exist to prevent mother-to-child transmission (MTCT) of the hepatitis B virus (HBV). These include providing Hepatitis B vaccination and hepatitis B immunoglobulin (HBIG) injection with different types of administration and dosages. The aim of this study is threefold: first, to evaluate the economic viability of current hepatitis B vaccination strategies for preventing MTCT from a public health policy perspective; second, to optimize the current immunization strategy for preventing perinatal transmission of the HBV; and third, to offer policy options to the National Health Commission in China. METHODS: To simulate the disease outcome for the entire life of newborns infected with HBV, a Markov model with eight possible health states was built by using TreeAge Pro 2011 software. In the present study, the model parameters were probability and cost, which were extracted from literature and calculated using Microsoft Excel 2013. The optimal immunization strategies were identified through cost-benefit analyses. A benefit-cost ratio (BCR) > 1 indicated that the strategy had positive benefits and vice versa. A one-way sensitivity analysis was used to investigate the stability of the results. RESULTS: From a public health care system perspective, we evaluated the economic viability of 11 strategies in China. For all 11 strategies, the BCR was > 1, which indicated that the benefits of all the strategies were greater than the costs. We recommended strategy number 9 as being optimal. In strategy number 9, babies born to hepatitis B surface antigen (HBsAg)-positive mothers were given an HBIG (200 IU) within 24 h of birth and three injections of hepatitis -B vaccine (20-μg each) at 0, 1, and 6 months, and the strategy had a BCR of 4.61. The one-way sensitivity analysis revealed that the full vaccination coverage and effective rates of protection were two factors that greatly influenced the BCR of the different prevention strategies; other factors had little effect. CONCLUSION: The benefits of all strategies were greater than the costs. For decision-making and application, the strategy should be based on local socio-economic conditions so that an appropriate immunization strategy can be selected.
format Online
Article
Text
id pubmed-9256498
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92564982022-07-06 Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree Yang, Nan Lei, Lei Meng, Yiyu Zhou, Naitong Shi, Lizheng Hu, Ming Front Public Health Public Health OBJECTIVES: Currently, in China, several strategies exist to prevent mother-to-child transmission (MTCT) of the hepatitis B virus (HBV). These include providing Hepatitis B vaccination and hepatitis B immunoglobulin (HBIG) injection with different types of administration and dosages. The aim of this study is threefold: first, to evaluate the economic viability of current hepatitis B vaccination strategies for preventing MTCT from a public health policy perspective; second, to optimize the current immunization strategy for preventing perinatal transmission of the HBV; and third, to offer policy options to the National Health Commission in China. METHODS: To simulate the disease outcome for the entire life of newborns infected with HBV, a Markov model with eight possible health states was built by using TreeAge Pro 2011 software. In the present study, the model parameters were probability and cost, which were extracted from literature and calculated using Microsoft Excel 2013. The optimal immunization strategies were identified through cost-benefit analyses. A benefit-cost ratio (BCR) > 1 indicated that the strategy had positive benefits and vice versa. A one-way sensitivity analysis was used to investigate the stability of the results. RESULTS: From a public health care system perspective, we evaluated the economic viability of 11 strategies in China. For all 11 strategies, the BCR was > 1, which indicated that the benefits of all the strategies were greater than the costs. We recommended strategy number 9 as being optimal. In strategy number 9, babies born to hepatitis B surface antigen (HBsAg)-positive mothers were given an HBIG (200 IU) within 24 h of birth and three injections of hepatitis -B vaccine (20-μg each) at 0, 1, and 6 months, and the strategy had a BCR of 4.61. The one-way sensitivity analysis revealed that the full vaccination coverage and effective rates of protection were two factors that greatly influenced the BCR of the different prevention strategies; other factors had little effect. CONCLUSION: The benefits of all strategies were greater than the costs. For decision-making and application, the strategy should be based on local socio-economic conditions so that an appropriate immunization strategy can be selected. Frontiers Media S.A. 2022-06-21 /pmc/articles/PMC9256498/ /pubmed/35801242 http://dx.doi.org/10.3389/fpubh.2022.662442 Text en Copyright © 2022 Yang, Lei, Meng, Zhou, Shi and Hu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yang, Nan
Lei, Lei
Meng, Yiyu
Zhou, Naitong
Shi, Lizheng
Hu, Ming
Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
title Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
title_full Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
title_fullStr Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
title_full_unstemmed Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
title_short Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
title_sort cost-benefit analysis of vaccination strategies to prevent mother-to-child transmission of the hepatitis b virus using a markov model decision tree
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256498/
https://www.ncbi.nlm.nih.gov/pubmed/35801242
http://dx.doi.org/10.3389/fpubh.2022.662442
work_keys_str_mv AT yangnan costbenefitanalysisofvaccinationstrategiestopreventmothertochildtransmissionofthehepatitisbvirususingamarkovmodeldecisiontree
AT leilei costbenefitanalysisofvaccinationstrategiestopreventmothertochildtransmissionofthehepatitisbvirususingamarkovmodeldecisiontree
AT mengyiyu costbenefitanalysisofvaccinationstrategiestopreventmothertochildtransmissionofthehepatitisbvirususingamarkovmodeldecisiontree
AT zhounaitong costbenefitanalysisofvaccinationstrategiestopreventmothertochildtransmissionofthehepatitisbvirususingamarkovmodeldecisiontree
AT shilizheng costbenefitanalysisofvaccinationstrategiestopreventmothertochildtransmissionofthehepatitisbvirususingamarkovmodeldecisiontree
AT huming costbenefitanalysisofvaccinationstrategiestopreventmothertochildtransmissionofthehepatitisbvirususingamarkovmodeldecisiontree